Paul Caldron
Rheumatology · Phoenix, AZNPI 1366433070
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,160 of the $35,615 with a category attached, or 81.9%. 23 manufacturers reported payments, led by Gilead at 44.3% of the total.
Across 273 payments — averaging $130.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$16K
- Cardinal Health 108 LLC$11K
- Johnson & Johnson$5K
- Amgen$813
- AbbVie$560
- Pfizer$521
- plus $2K from 17 others
Across 60 payments — averaging $3336.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$59K
- Astrazeneca UK Limited$40K
- Eli Lilly$26K
- Janssen Research & Development, LLC$25K
- Pfizer$20K
- Sun Pharmaceutical Industries Inc.$9K
- plus $21K from 5 others
What the payments were for
- Consulting fees$29,16082%
- Travel & lodging$2,3767%
- Food & beverage$4,07211%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 15 | $15,767 |
| Cardinal Health 108 LLC | 2 | $11,250 |
| Johnson & Johnson(2 entities) | 16 | $5,047 |
| Amgen(2 entities) | 56 | $813 |
| AbbVie | 36 | $560 |
| Pfizer | 37 | $521 |
| E.r. Squibb & Sons, L.L.C. | 20 | $263 |
| Lilly USA, LLC | 21 | $260 |
| Genentech USA, Inc. | 15 | $221 |
| Sanofi | 10 | $196 |
| Bristol Myers Squibb | 9 | $157 |
| Novartis | 10 | $130 |
| GSK | 6 | $82 |
| Boehringer Ingelheim | 4 | $71 |
| UCB, Inc. | 4 | $67 |
| Radius Health, Inc. | 3 | $56 |
| Mallinckrodt Enterprises LLC | 2 | $46 |
| Hikma Pharmaceuticals USA | 2 | $23 |
| Sobi, Inc | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| Merck | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$4,787
How this compares
$35,615 in reported general payments places this provider in the 85th percentile of 102 rheumatology providers in Arizona.
Other rheumatology in Phoenix
- Nehad SolomanPhoenix$1.3M
- John TesserPhoenix$999K
- Saima ChohanPhoenix$22K
- Nikila KumarPhoenix$20K
- Matthew HerrmannPhoenix$11K
- Trent SmithPhoenix$9K
- Swati BharadwajPhoenix$9K
- Alan MallacePhoenix$4K
- Kristen YoungPhoenix$3K
- Joy SchechtmanPeoria$860K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.